7726.Two
7726.TWO operates in the healthcare services and equipment industry, providing medical equipment, supplies, and distribution services.
Business. 7726.TWO operates in the healthcare services and equipment industry, providing medical equipment, supplies, and distribution services.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
7726.TWO operates in the healthcare services and equipment industry, providing medical equipment, supplies, and distribution services.
The company maintains a debt-to-equity ratio of 0.59, indicating a moderate reliance on debt financing relative to equity. Its liquidity position is assessed as medium, with a negative net cash position after subtracting total debt, suggesting potential short-term liquidity constraints. The operating cash flow of 46,566,000 TWD supports ongoing operations, but the capital expenditure of -10,523,000 TWD indicates some investment in long-term assets.
Profitability and returns are not explicitly detailed in the provided data, but the company's operating cash flow suggests a positive cash generation capability. However, without specific metrics such as return on invested capital (ROIC) or net profit margin, a direct comparison to industry benchmarks is not possible.
The company's revenue concentration and geographic exposure are not specified in the available data, making it difficult to assess the risk associated with over-reliance on particular segments or regions.
The company's growth trajectory is not explicitly outlined in the provided data. However, the operating cash flow and capital expenditure figures suggest a balance between maintaining operations and investing in future growth.
The risk assessment indicates a medium liquidity risk and a low dilution risk. The key flag of negative net cash after subtracting total debt highlights a potential liquidity constraint. No specific dilution sources are identified in the provided data, and the dilution risk is assessed as low.
Recent events, such as filings or transcripts, are not detailed in the provided data, limiting the ability to assess the company's recent performance and strategic direction.
- The company has a moderate debt-to-equity ratio of 0.59, indicating a balanced capital structure.
- The liquidity position is assessed as medium, with a negative net cash position after subtracting total debt.
- The operating cash flow of 46,566,000 TWD supports ongoing operations, but the capital expenditure of -10,523,000 TWD indicates some investment in long-term assets.
- The company's growth trajectory is not explicitly outlined in the provided data.
- The risk assessment indicates a medium liquidity risk and a low dilution risk.
- Recent events, such as filings or transcripts, are not detailed in the provided data.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- 7726.TWO Market data — financials · 2026-05-27